Royalty Pharma Stock Options Expiring on 21st of February
| RPRX Stock | USD 30.30 0.45 1.46% |
Royalty Pharma's latest option contracts expiring on February 21st 2025 are carrying combined implied volatility of 0.76 with a put-to-call open interest ratio of 0.25 over 20 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on February 21st 2025. The total put volume is at 13.0, with calls trading at the volume of 102. This yields a 0.13 put-to-call volume ratio.
Open Interest Against February 21st 2025 Option Contracts
Royalty Pharma option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Royalty Pharma's lending market. For example, when Royalty Pharma's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Royalty Pharma, he or she must hedge the risk by shorting Royalty Pharma stock over its option's life.
2025-02-21
The chart above shows Royalty Pharma's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Royalty Pharma's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Royalty Pharma's option, there is no secondary market available for investors to trade.
Royalty Pharma Plc In The Money Call Balance
When Royalty Pharma's strike price is surpassing the current stock price, the option contract against Royalty Pharma Plc stock is said to be in the money. When it comes to buying Royalty Pharma's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Royalty Pharma Plc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Royalty Current Options Market Mood
Royalty Pharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Royalty Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Royalty Pharma's options investors are not very successful. Royalty Pharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Royalty contract
Base on the Rule 16, the options market is currently suggesting that Royalty Pharma Plc will have an average daily up or down price movement of about 0.0475% per day over the life of the 2025-02-21 option contract. With Royalty Pharma trading at USD 30.3, that is roughly USD 0.0144. If you think that the market is fully incorporating Royalty Pharma's daily price movement you should consider buying Royalty Pharma Plc options at the current volatility level of 0.76%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Royalty |
Royalty Pharma Option Chain
When Royalty Pharma's strike price is surpassing the current stock price, the option contract against Royalty Pharma Plc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Royalty Pharma's option chain is a display of a range of information that helps investors for ways to trade options on Royalty. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Royalty. It also shows strike prices and maturity days for a Royalty Pharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | RPRX250221C00020000 | 3 | 20.0 | 8.5 - 13.0 | 5.5 | In |
Call | RPRX250221C00022500 | 0 | 22.5 | 6.1 - 10.5 | 6.1 | In |
Call | RPRX250221C00025000 | 6 | 25.0 | 4.0 - 8.0 | 2.5 | In |
Call | RPRX250221C00027500 | 117 | 27.5 | 2.8 - 4.9 | 2.96 | In |
Call | RPRX250221C00030000 | 185 | 30.0 | 0.9 - 1.2 | 1.25 | In |
Call | RPRX250221C00032500 | 151 | 32.5 | 0.15 - 0.4 | 0.15 | Out |
Call | RPRX250221C00035000 | 20 | 35.0 | 0.0 - 0.25 | 0.05 | Out |
Call | RPRX250221C00037500 | 0 | 37.5 | 0.0 - 0.15 | 0.15 | |
Call | RPRX250221C00040000 | 0 | 40.0 | 0.0 - 0.45 | 0.45 | |
Call | RPRX250221C00042500 | 0 | 42.5 | 0.0 - 3.0 | 3.0 | |
Put | RPRX250221P00020000 | 0 | 20.0 | 0.0 - 0.3 | 0.3 | |
Put | RPRX250221P00022500 | 5 | 22.5 | 0.0 - 2.55 | 0.05 | Out |
Put | RPRX250221P00025000 | 55 | 25.0 | 0.0 - 0.05 | 0.1 | Out |
Put | RPRX250221P00027500 | 50 | 27.5 | 0.0 - 0.25 | 0.1 | Out |
Put | RPRX250221P00030000 | 9 | 30.0 | 0.0 - 0.85 | 0.7 | Out |
Put | RPRX250221P00032500 | 0 | 32.5 | 0.0 - 3.4 | 3.4 | In |
Put | RPRX250221P00035000 | 0 | 35.0 | 2.5 - 6.0 | 2.5 | In |
Put | RPRX250221P00037500 | 1 | 37.5 | 5.0 - 8.9 | 9.0 | In |
Put | RPRX250221P00040000 | 0 | 40.0 | 7.4 - 11.8 | 7.4 | In |
Put | RPRX250221P00042500 | 0 | 42.5 | 9.6 - 14.5 | 9.6 | In |
Royalty Total Stockholder Equity
Total Stockholder Equity |
|
Royalty Pharma Corporate Management
| Eric Schneider | Senior Officer | Profile | |
| George Lloyd | Executive Officer | Profile | |
| Marshall MD | Executive Investments | Profile | |
| Sandy Balkin | Senior Analytics | Profile | |
| Sara Klymkowsky | Senior Investments | Profile | |
| Ashwin MD | Executive Investments | Profile |
Additional Tools for Royalty Stock Analysis
When running Royalty Pharma's price analysis, check to measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.